MERILOG Trademark

Trademark Overview

On Thursday, October 6, 2022, a trademark application was filed for MERILOG with the United States Patent and Trademark Office. The USPTO has given the MERILOG trademark a serial number of 97621322. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, November 6, 2024. This trademark is owned by Sanofi. The MERILOG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating diabetes
merilog

General Information

Serial Number97621322
Word MarkMERILOG
Filing DateThursday, October 6, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, November 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParis 75017
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75017
FR

Trademark Events

Event DateEvent Description
Monday, October 10, 2022NEW APPLICATION ENTERED
Tuesday, October 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 24, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, December 15, 2022ASSIGNED TO LIE
Thursday, December 15, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, February 23, 2023ASSIGNED TO EXAMINER
Friday, March 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 3, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 3, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 3, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 11, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 3, 2023SOU EXTENSION 1 FILED
Friday, November 3, 2023SOU EXTENSION 1 GRANTED
Tuesday, November 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 17, 2024SOU EXTENSION 2 FILED
Wednesday, April 17, 2024SOU EXTENSION 2 GRANTED
Thursday, April 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 6, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, November 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 6, 2024SOU EXTENSION 3 GRANTED
Wednesday, November 6, 2024SOU EXTENSION 3 FILED

Related Keywords

merilog diabetes treating preparations pharmaceutical